Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: An NRG oncology/ gynecologic oncology group study

Martee L. Hensley, Austin Miller, David M. O'Malley, Robert S. Mannel, Kian Behbakht, Jamie N. Bakkum-Gamez, Helen Michael

Research output: Contribution to journalArticle

66 Scopus citations
Original languageEnglish (US)
Pages (from-to)1180-1185
Number of pages6
JournalJournal of Clinical Oncology
Volume33
Issue number10
DOIs
StatePublished - Apr 1 2015

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this